Tianyu Co., Ltd. announced that Zhejiang Nuode Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for vardenafil hydrochloride tablets approved and issued by the State Drug Administration. The specification of this drug is 10 mg, and the registered classification is chemical class 4. The drug approval number is Sinopharm standard H20265478. It is valid until August 3, 2031. The indication is to treat male penile erectile dysfunction. As of the announcement date, domestic manufacturers include Shandong Langnuo Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd., and Guangxi Qiangshou Pharmaceutical Group Co., Ltd. In 2025, the sales volume of the drug in domestic sample hospitals and physical pharmacies in cities was about 14 million yuan. The product was accepted in May 2025. As of July 31, 2026, the company and its subsidiaries had invested a total of about 6.628,600 yuan in R&D.

Tianyu Co., Ltd. announced that Zhejiang Nuode Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for vardenafil hydrochloride tablets approved and issued by the State Drug Administration. The drug specification is 10 mg, and the registered classification is chemical class 4. The drug approval number is Sinopharm approval number H20265478. It is valid until August 3, 2031. The indication is to treat male penile erectile dysfunction. As of the announcement date, domestic manufacturers include Shandong Langnuo Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd., and Guangxi Qiangshou Pharmaceutical Group Co., Ltd. In 2025, the sales volume of the drug in domestic sample hospitals and physical pharmacies in cities was about 14 million yuan. The product was accepted in May 2025. As of July 31, 2026, the company and its subsidiaries had invested a total of about 6.628,600 yuan in R&D.